Ben Walthall

Dr. Ben Walthall provides support in new product development and expanding the use of the RenovaCare technology platform for medical conditions beyond burns.

During a career spanning almost four decades, Dr. Walthall served as R&D Worldwide Director for Johnson & Johnson, Surgical Wound Care, where he was responsible for technology strategy, portfolio management, and product development programs.

While at Johnson and Johnson, he also served as Worldwide Director R&D of Tissue Regeneration and previously as Worldwide Director R&D Advanced Wound Care.

In these roles, Dr. Walthall created a new tissue regeneration business and developed technologies to clinically utilize novel tissue engineering scaffolds for skin repair and advanced wound care.

Following Johnson & Johnson, Dr. Ben Walthall served as Vice President of Biologics R&D for Zimmer Biomet, the largest pure-play orthopedic company in the world. At Zimmer, he was responsible for product development and commercialization of various technologies for bone, spine, soft tissue, and cartilage repair.

He previously served on the Board of the Wound Healing Society and on the Advisory Boards for UCLA and Georgia Tech biomedical departments.

Dr. Walthall is the author of numerous peer-reviewed articles and holds several patents in the biomedical field. He holds a Bachelor of Science degree in Chemistry and a Ph.D. in Biochemistry from the University of Texas and completed Postdoctoral work in Cell Biology at the University of Colorado.